Trending Topic

Stastical analysis indication diabetes mellitus .generative ai
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Saptarshi Bhattacharya, Sanjay Kalra, Lakshmi Nagendra

Very few trials in the history of medical science have altered the treatment landscape as profoundly as the UK Prospective Diabetes Study (UKPDS). Even 44 years after its inception, the trial and post-study follow-up findings continue to fascinate and enlighten the medical community. The study was conceived at a time when there was uncertainty about […]

touchLearning Activities

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Mark CompleteCompleted
BookmarkBookmarked

In 2025, the International Diabetes Federation (IDF) will host its World Diabetes Congress in Bangkok, Thailand, from 7-10 April. It will be my immense pleasure to welcome you there as President of the International Diabetes Federation, along with a new Board ...

Mark CompleteCompleted
BookmarkBookmarked

New research has introduced a strategy that could considerably reduce the need for insulin therapy in patients with type 2 diabetes (T2D)

Mark CompleteCompleted
BookmarkBookmarked

For hundreds of millions worldwide, diabetes is not just a physical condition, it’s an around-the-clock emotional challenge. Hearing from advocates around the world ahead of World Diabetes Day, it’s clear this burden is shared across the entire diabetes community. Our advocate from Zimbabwe described the constant vigilance and decision-making required to manage his condition, while in Spain they reflected on the unchosen limitations diabetes places on daily life. In India, another advocate highlighted the intense mental strain of balancing work, rest and nutrition. These experiences reveal how daily diabetes management imposes a hidden burden on mental well-being, which is largely unseen by society and unaddressed by healthcare systems.

Mark CompleteCompleted
BookmarkBookmarked

MACE reduction was a key finding in the topline results from the Semaglutide Cardiovascular Outcomes Trial (SOUL), which reported that oral semaglutide, a long-acting Glucagon-Like Peptide-1 (GLP-1) receptor agonist, significantly decreases the risk of major adverse cardiovascular events in adults with type 2 diabetes (T2D) who have established atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD).

Mark CompleteCompleted
BookmarkBookmarked

touchENDOCRINOLOGY was delighted to speak with Editorial Board member Dr Deep Dutta, a senior endocrinologist at the CEDAR Superspecialty Clinics, New Delhi, India. Throughout this interview, he summarizes the key messages from his late-breaking abstract session ‘Ailing Heart, Broken Vessels’, presented at the 60th European Association for the Study of Diabetes (EASD) annual meeting in Madrid, Spain.

Mark CompleteCompleted
BookmarkBookmarked

In this expert Q&A we are delighted to welcome our Editorial Board member Dr Sanjay Kalra, a leading endocrinologist with over two decades of experience at Bharti Hospital, Karnal, India. A passionate educator and researcher, Dr Kalra serves as Education Editor of the International Society of Endocrinology (ISE) and is deeply involved in global endocrine education. His leadership extends to roles such as Immediate Past President of the Endocrine Society of India and Vice-President of the South Asian Federation of Endocrine Societies.

Mark CompleteCompleted
BookmarkBookmarked

Olaf Dekkers highlights this new European Society of Endocrinology and Endocrine Society Joint Clinical Guideline,1 the first of many future collaborations

Mark CompleteCompleted
BookmarkBookmarked

Established more than 25 years ago, the Immunology of Diabetes Society (IDS) is dedicated to improving our understanding of the mechanisms by which the immune system and the pancreas contribute to the development of type 1 diabetes (T1D). Every 18 months, the ...

Mark CompleteCompleted
BookmarkBookmarked

Tthe American Association of Clinical Endocrinology (AACE) is a global, inclusive community of endocrine-focused members and stakeholders from diverse professional backgrounds.

Mark CompleteCompleted
BookmarkBookmarked

We're looking forward to the 60th anniversary of the EASD Annual Meeting 2024, which is taking place in Madrid between 9-13 September 2024. Promising attendees an opportunity to explore the latest technologies, treatments, and products in the field of diabetes, we are ...

Mark CompleteCompleted
BookmarkBookmarked

The European Association for the Study of Diabetes (EASD) is set to host its 60th Annual Meeting from 9 to 13 September 2024, in Madrid, Spain. This milestone marks a significant moment in the history of diabetes research and care, showcasing the growth and achievements of the EASD Annual Meeting, now the largest diabetes conference in the world.

Mark CompleteCompleted
BookmarkBookmarked

We're excited to introduce a new series of expert Q&As featuring members of the touchREVIEWS in Endocrinology editorial board and faculty. In this series, they will share key career milestones, offer valuable advice for aspiring future leaders, and provide forward-looking insights into their areas of expertise.

Mark CompleteCompleted
BookmarkBookmarked

A recent study published in the BMJ has revealed a startling increase in the global prevalence of older individuals living with Type 1 diabetes mellitus (T1DM). Over the past three decades, the number of people aged 65 and older with T1DM has surged by 180%, underscoring the urgent need for enhanced healthcare strategies and resources for this demographic.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

‘Closed-loop’ systems mark a significant advancement in managing type 1 diabetes. These systems which continuously monitor glucose levels and automatically deliver insulin through a pump, help many individuals with type 1 diabetes maintain optimal glucose levels with greater ease. In this episode, we explore the progress, challenges and impact of these innovative technologies with Endocrinology Clinical Pharmacy Specialist, Dr Diana Isaacs, and highlight their future potential.

Mark CompleteCompleted
BookmarkBookmarked

The European Association for the Study of Obesity (EASO) has introduced a new framework for the diagnosis, staging and management of obesity in adults.

Mark CompleteCompleted
BookmarkBookmarked

The American Diabetes Association (ADA) 84th Scientific Sessions took place in Orlando, Florida from 21–24 June, offering a wealth of updates and new data in diabetes and related specialties. The touchENDOCRINOLOGY team monitored the event on X to track the trending topics under #ADA2024.

Mark CompleteCompleted
BookmarkBookmarked

Members of the endocrinology community gathered in Stockholm, Sweden, for the 26th European Congress of Endocrinology (ECE 2024), eager to explore the latest advancements and exchange knowledge and insights. Here are some of the standout abstracts that captured our attention:

32 mins
Sponsored Content
touchMEETING HIGHLIGHTS
For HCPs in: Global excluding US, Japan, and China

Watch leading experts Prof. Moshe Phillip, Dr Sandro Loche and Prof. Antonio de Arriba discuss challenges in growth hormone disease management, and how digital health tools and data analytics can support HCPs and improve outcomes for patients.

Load More...
touchENDOCRINOLOGY touchENDOCRINOLOGY

Register Now!

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

  • Save your progress for video
  • Keep track of your CME credits
  • Add personalised learning notes
  • Receive updates from course leaders and faculty
  • Be the first to hear about new and exciting interactive learning opportunities
Close Popup